82_FR_20692 82 FR 20608 - National Institute of Mental Health; Notice of Meeting

82 FR 20608 - National Institute of Mental Health; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 84 (May 3, 2017)

Page Range20608-20608
FR Document2017-08938

Federal Register, Volume 82 Issue 84 (Wednesday, May 3, 2017)
[Federal Register Volume 82, Number 84 (Wednesday, May 3, 2017)]
[Notices]
[Page 20608]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-08938]



[[Page 20608]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Advisory Mental Health Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or proposals and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Advisory Mental Health Council.
    Date: May 25, 2017.
    Open: 9:00 a.m. to 12:15 p.m.
    Agenda: Presentation of the NIMH Director's Report and 
discussion of NIMH program.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852.
    Closed: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852.
    Contact Person: Jean G. Noronha, Ph.D., Director, Division of 
Extramural Activities, National Institute of Mental Health, NIH, 
Neuroscience Center, 6001 Executive Blvd., Room 6154, MSC 9609, 
Bethesda, MD 20892-9609, 301-443-3367, [email protected].

    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: www.nimh.nih.gov/about/advisory-boards-and-groups/namhc/index.shtml., where an agenda and any additional information for the 
meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental 
Health Research Grants, National Institutes of Health, HHS)

    Dated: April 28, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-08938 Filed 5-2-17; 8:45 am]
 BILLING CODE 4140-01-P



                                               20608                         Federal Register / Vol. 82, No. 84 / Wednesday, May 3, 2017 / Notices

                                               DEPARTMENT OF HEALTH AND                                and electronic copies are requested for the           announcement incorrectly stated that
                                               HUMAN SERVICES                                          record. In addition, any interested person            the device was to be included as part of
                                                                                                       may file written comments with the                    the submission for Step 2.
                                               National Institutes of Health                           committee by forwarding their statement to               (3) The Technical Evaluation Panel
                                                                                                       the Contact Person listed on this notice. The         will use the following 4 criteria for
                                               National Institute of Mental Health;                    statement should include the name, address,
                                                                                                       telephone number and when applicable, the
                                                                                                                                                             evaluating the Step 2 submissions
                                               Notice of Meeting                                                                                             including: (a) Innovation; (b) clinical
                                                                                                       business or professional affiliation of the
                                                  Pursuant to section 10(d) of the                     interested person.                                    significance; (c) diagnostic performance
                                               Federal Advisory Committee Act, as                         Information is also available on the               and feasibility; and (d) sample matrix/
                                               amended (5 U.S.C. App.), notice is                      Institute’s/Center’s home page:                       setting and ease of use/throughput.
                                               hereby given of a meeting of the                        www.nimh.nih.gov/about/advisory-boards-               These criteria were defined in the
                                                                                                       and-groups/namhc/index.shtml., where an               September 8, 2016, announcement;
                                               National Advisory Mental Health                         agenda and any additional information for
                                               Council.                                                                                                      however, the announcement incorrectly
                                                                                                       the meeting will be posted when available.            stated that the Panel will evaluate the
                                                  The meeting will be open to the
                                               public as indicated below, with                         (Catalogue of Federal Domestic Assistance             solutions based on eight criteria.
                                               attendance limited to space available.                  Program No. 93.242, Mental Health Research               (4) A description sufficiently detailed
                                                                                                       Grants, National Institutes of Health, HHS)           and organized by sections for evaluation
                                               Individuals who plan to attend and
                                               need special assistance, such as sign                     Dated: April 28, 2017.                              in the technical review and
                                               language interpretation or other                        Melanie J. Pantoja,                                   programmatic assessment of the
                                               reasonable accommodations, should                       Program Analyst, Office of Federal Advisory           proposed solution in 15 pages or less
                                               notify the Contact Person listed below                  Committee Policy.                                     including the next 6 bullets, 8.5 x 11
                                               in advance of the meeting.                              [FR Doc. 2017–08938 Filed 5–2–17; 8:45 am]            inch page, 10-point or greater Arial,
                                                  The meeting will be closed to the                    BILLING CODE 4140–01–P
                                                                                                                                                             Palatino Linotype, or Georgia font and
                                               public in accordance with the                                                                                 one inch margins including:
                                               provisions set forth in sections                                                                                 • A title of the proposed solution;
                                               552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,              DEPARTMENT OF HEALTH AND                                 • A detailed description of the
                                               as amended. The grant applications                      HUMAN SERVICES                                        proposed in vitro diagnostic, and the
                                               and/or proposals and the discussions                                                                          development approach, challenges, and
                                               could disclose confidential trade secrets               National Institutes of Health                         risks;
                                                                                                                                                                • One section addressing each of the
                                               or commercial property such as
                                                                                                       Notice of Correction for                              4 criteria listed above;
                                               patentable material, and personal                                                                                • One section providing a summary
                                               information concerning individuals                      Announcement of Requirements and
                                                                                                       Registration for ‘‘Antimicrobial                      of the data, using the in vitro diagnostic
                                               associated with the grant applications,                                                                       device and the Standard Operating
                                               the disclosure of which would                           Resistance Rapid, Point-of-Need
                                                                                                       Diagnostic Test’’ Challenge                           Procedures described in Appendix B,
                                               constitute a clearly unwarranted                                                                              generated with either clinical or
                                               invasion of personal privacy.                              The National Institutes of Health                  contrived samples compared to existing
                                                 Name of Committee: National Advisory                  (NIH) is correcting a notice previously               standard techniques demonstrating the
                                               Mental Health Council.                                  published in the Federal Register on                  performance characteristics (e.g., limits
                                                 Date: May 25, 2017.                                   September 8, 2016 (81 FR 62150), titled               of detection, sensitivity, specificity, and
                                                 Open: 9:00 a.m. to 12:15 p.m.                         ‘‘Announcement of Requirements and                    other characteristics that demonstrate
                                                 Agenda: Presentation of the NIMH                      Registration for ‘‘Antimicrobial
                                               Director’s Report and discussion of NIMH                                                                      test performance to support detection of
                                               program.
                                                                                                       Resistance Rapid, Point-of-Need                       biomarkers or analytes). The September
                                                 Place: National Institutes of Health,                 Diagnostic Test’’ Challenge.’’ The notice             8, 2016, announcement incorrectly
                                               Neuroscience Center, 6001 Executive                     announced the Antimicrobial Resistance                stated that diagnostic performance
                                               Boulevard, Rockville, MD 20852.                         Rapid, Point-of-Need challenge                        characteristics included positive
                                                 Closed: 1:00 p.m. to 5:00 p.m.                        competition that may result in the                    predictive value and negative predictive
                                                 Agenda: To review and evaluate grant                  awarding of $20 million dollars for the               value;
                                               applications and/or proposals.                          successful development of new,                           • Photographs of the in vitro
                                                 Place: National Institutes of Health,                 innovative, accurate, and cost-effective
                                               Neuroscience Center, 6001 Executive
                                                                                                                                                             diagnostic prototype device and a video
                                                                                                       in vitro diagnostic tests that would                  not to exceed 5 minutes (in accordance
                                               Boulevard, Rockville, MD 20852.
                                                 Contact Person: Jean G. Noronha, Ph.D.,               rapidly inform clinical treatment                     with the NIH interim policy for
                                               Director, Division of Extramural Activities,            decisions and be of significant clinical              submitting a video as NIH application
                                               National Institute of Mental Health, NIH,               and public health utility to combat the               materials https://grants.nih.gov/grants/
                                               Neuroscience Center, 6001 Executive Blvd.,              development and spread of antibiotic                  guide/notice-files/NOT-OD-12-141.html)
                                               Room 6154, MSC 9609, Bethesda, MD 20892–                resistant bacteria and improve antibiotic             demonstrating the status of the
                                               9609, 301–443–3367, jnoronha@mail.nih.gov.              stewardship.                                          development and actual use of the
                                                  Any member of the public interested in                  The NIH is correcting and clarifying               device in testing contrived or clinical
                                               presenting oral comments to the committee               several components of Step 2 of the                   specimens;
                                               may notify the Contact Person listed on this            Challenge competition including:                         • Address the NIH Human Subjects
                                               notice at least 10 days in advance of the                  (1) The letter of intent must be                   Protections and Inclusion of Women,
                                               meeting. Interested individuals and                     submitted by August 3, 2018, at 11:59                 Children, and Minorities policies, as
nlaroche on DSK30NT082PROD with NOTICES




                                               representatives of organizations may submit             p.m. ET, for all ‘‘Solvers’’ planning to              well as biohazards policies (https://
                                               a letter of intent, a brief description of the
                                                                                                       submit for the Step 2 (Delivery of                    grants.nih.gov/grants/guide/notice-files/
                                               organization represented, and a short
                                               description of the oral presentation. Only one          Prototype and Analytical Data) stage of               NOT-OD-15-078.html), if applicable.
                                               representative of an organization may be                the competition.                                         (5) An Appendix A, provide
                                               allowed to present oral comments and if                    (2) The prototype in vitro diagnostic              additional data and tables to support the
                                               accepted by the committee, presentations                device is not to be provided with the                 data summary and performance claims
                                               may be limited to five minutes. Both printed            submission. The September 8, 2016,                    based on the use of the proposed


                                          VerDate Sep<11>2014   14:29 May 02, 2017   Jkt 241001   PO 00000   Frm 00050   Fmt 4703   Sfmt 4703   E:\FR\FM\03MYN1.SGM   03MYN1



Document Created: 2018-11-08 08:36:53
Document Modified: 2018-11-08 08:36:53
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMay 25, 2017.
FR Citation82 FR 20608 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR